Latest

Latest MD Anderson Cancer Center News

  • Latest MD Anderson Cancer Center news stories and updates. What is happening today? All recent MD Anderson Cancer Center news and developments. Live coverage and timeline of MD Anderson Cancer Center. All you need to know about MD Anderson Cancer Center.
QIMR Berghofer and CTMC announce strategic collaboration in cell and gene therapy through the CTMC Global Network Alliance
Oral drug combination eases treatment burden for AML patients
Targeting inflammation may help overcome drug resistance in colon cancer
Dr. Thomas Coffman to give Baylor College of Medicine commencement address
There is more than one way for triple-negative breast cancer to become resistant to therapy
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research
TMC Collaboration: Training New Kidney, Urologic And Hematologic Researchers
Surprising Structure Discovered In Disordered Protein
Manchester scientists are world’s most cited on deadly fungal disease
Single-cell RNA sequencing of bone metastases from multiple cancer types reveals three distinct immune archetypes
Baylor researchers develop and validate clinical diagnostic RNA sequencing test
Researchers discovered replication hubs for human norovirus
Researchers discover localised pain relief using known chemical reaction
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer
Inflammation leaves a long-lasting impression on intestinal stem cells
Dr. Shanda Blackmon named director of The Lung Institute at Baylor Medicine
Discovery suggests new strategy against follicular lymphoma
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
Chimeric Therapeutics completes placement with shortfall commitments
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Imfinzi plus Lynparza reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer
TRISH selects 2023 class of space health postdoctoral fellows
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
Breast cancer tumors disrupt the immune system remotely favoring their own growth
Gene Tiam1 orchestrates the development of chronic neuropathic pain
Imfinzi-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell…
Imfinzi significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer
Study helps explain severe graft-versus-host disease and potential solution
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
WHO and MD Anderson launch new partnership to reduce global burden of women’s cancers
Dissemination of bone metastasis linked with bone remodeling
Promising approach to mitigate complications of leukemia treatment
Hormone-blocking breakthrough helps combat skin cancer recurrence
Hormone-blocking breakthrough helps combat skin cancer recurrence
Ovarian cancer’s advance slowed by drug
Study highlights role of disordered protein interactions in gene expression
Maryland health care payment model reduces costs and complications, study shows
AI-powered microscope could check cancer margins in minutes
Dr. Ramsay Camp named chief of surgical oncology
Chan Zuckerberg Initiative supports diversity in Human Cell Atlas project
Three research teams earn Dunn Awards
Novel PROTAC enhances its intracellular accumulation and protein knockdown
Protein ‘chameleon’ colors long-term memory
Researchers enrolling patients for study to train AI in assisting breast cancer surgery
COVID-19 research funds back six new initiatives
Testing tuberculosis vaccine for COVID-19

© 2026 - The National Tribune Australia